Friday, Jul 24, 2026 The claims desk. Receipts included. POWERED BY LENZ
IsThis

HEALTH

The Claim

South Korea has an approved medical treatment that regenerates knee cartilage in humans.

The Short Version

South Korea does have an approved human treatment for knee cartilage defects that is described in regulatory, clinical, and independent sources as a regenerative cell therapy. The strongest evidence is MFDS approval of CARTISTEM and supporting clinical literature. The main caveat is that approval is for specific knee cartilage defects, not all forms of knee cartilage loss, and regeneration is not guaranteed in every patient.

Caveats

  • The approved use is not for every knee problem; it is limited to specific cartilage defects and patient indications.
  • "Regenerates" should not be read as complete or uniform cartilage restoration in all patients; outcomes vary.
  • Some supporting materials are company or promotional sources, so the strongest weight belongs to MFDS records and peer-reviewed studies.

The Receipts

  1. Dry Arthroscopic Cartilage Repair of the Knee Joint Using Cartistem: A Technique Article

    PubMed Central

  2. Biological Products – CARTISTEM®

    Ministry of Food and Drug Safety (MFDS)

  3. Cartistem® Cord Blood-Derived Therapy for Knee Arthritis

    Parents Guide to Cord Blood

  4. S. Korea approves sales of new stem cell drug

    Medical Xpress

  5. [i-point] 바이오솔루션 '카티라이프', 한국 식약처 정식 품목허가

    thebell

  6. MEDIPOST's CARTISTEM® Reaches Milestone of treating 30000 patients in Korea

    MEDIPOST

  7. Korea Approves the World's First Cell and Gene Therapy for Knee Osteoarthritis

    PR Newswire

  8. Korea okays stem cell therapies despite limited peer-reviewed data

    Nature Medicine

  9. Advanced Therapy Medicinal Products for Autologous Chondrocytes in Cartilage Repair

    Bone & Joint Research (PMC)

  10. 식약처, ‘무릎 연골 재생 돕는 의료기기' 안전기준 마련

    헬스조선

+ 20 more sources — see the full list on Lenz

Filed Under

Knee Cartilage RegenerationSouth Korea

More Fact Checks